Drugs with highest community hospital spending U.S. per unit price 2017

This statistic displays the prcie per unit of the ten drugs with the highest spending by U.S. community hospitals in 2017. The figures are based on data from 1,800 community hospitals organized in two GPOs (group purchasing organizations). Within these GPOs, Activase - also known under its generic name alteplase - was the drug on which the most money was spent. The per unit price of Activase stood at 4,143 U.S. dollars that year.

Per unit price of drugs with the highest spending by U.S. community hospitals in 2017 (in U.S. dollars)

Characteristic	Price per unit in U.S. dollars
Harvoni (ledipasvir/sofosbuvir)	21,434
Neulasta (pegfilgrastim)	4,883
Activase (alteplase)	4,143
Enbrel (etanercept)**	2,931
Humira (adalimumab)*	2,840
Rituxan (rituximab)*	2,735
Prolia (denosumab)*	1,453
Remicade (infliximab)*	908
Procrit (epoetin alfa)*	209
Lexiscan (regadenoson)	207

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

January 2019

More information

Region

United States

Survey time period

2017

Number of respondents

1,800 respondents

Special properties

community hospitals included in 2 GPOs

Supplementary notes

* Indicates that the medication is an orphan drug and thus receives additional patent protections under the Orphan Drug Act.
** The biosimilar for Enbrel is not available for purchase due to an ongoing legal dispute.

Citation formats